Adial Awarded New Patent

 Strengthens Adial’s patent portfolio and covers AD04’s unique ability to target the serotonin transporter gene for the potential treatment of opioid use disorder

https://www.globenewswire.com/news-release/2024/02/28/2837060/26135/en/Adial-Pharmaceuticals-Awarded-New-Patent-from-the-United-States-Patent-and-Trademark-Office.html